Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss. Neurodegeneration is a broader term which comprises of different disease namely Parkinson’s disease, Huntington disease, Amyotrophic Lateral Sclerosis and Alzheimer’s disease. These are the most commonly occurring diseases under the condition “Neurodegeneration”.

The global Neurodegenerative Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neurodegenerative Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neurodegenerative Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neurodegenerative Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neurodegenerative Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA Pharmaceuticals
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
NMDA
SSRIs
Dopamine Inhibitors

Segment by Application
Hospital
Research